Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Biosimilar Collaborations Ireland Limited en Spain

Y
YESINTEK 130 mg CONCENTRATE FOR INFUSION SOLUTION
Dosage form:  INJECTABLE PERFUSION, 130 mg/26 ml
Active substance:  ustekinumab
Manufacturer:  Biosimilar Collaborations Ireland Limited
Prescription required
YESINTEK 45 mg Injectable Solution in Pre-filled Syringe
Dosage form:  INJECTABLE, 45 mg
Active substance:  ustekinumab
Manufacturer:  Biosimilar Collaborations Ireland Limited
Prescription required
YESINTEK 90 mg Injectable Solution in Pre-filled Syringe
Dosage form:  INJECTABLE, 90 mg
Active substance:  ustekinumab
Manufacturer:  Biosimilar Collaborations Ireland Limited
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media